Genetic variants and mutations of PPM1D control the response to DNA damage

Crissy Dudgeon, Sathyavageeswaran Shreeram, Kan Tanoue, Sharlyn J. Mazur, Ahmed Sayadi, Robert C. Robinson, Ettore Appella, Dmitry V. Bulavin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The Wip1 phosphatase is an oncogene that is overexpressed in a variety of primary human cancers. We were interested in identifying genetic variants that could change Wip1 activity. We identified 3 missense SNPs of the human Wip1 phosphatase, L120F, P322Q, and I496V confer a dominant-negative phenotype. On the other hand, in primary human cancers, PPM1D mutations commonly result in a gain-of-function phenotype, leading us to identify a hot-spot truncating mutation at position 525. Surprisingly, we also found a significant number of loss-of-function mutations of PPM1D in primary human cancers, both in the phosphatase domain and in the C terminus. Thus, PPM1D has evolved to generate genetic variants with lower activity, potentially providing a better fitness for the organism through suppression of multiple diseases. In cancer, however, the situation is more complex, and the presence of both activating and inhibiting mutations requires further investigation to understand their contribution to tumorigenesis.

Original languageEnglish
Pages (from-to)2656-2664
Number of pages9
JournalCell Cycle
Volume12
Issue number16
DOIs
Publication statusPublished - Aug 15 2013
Externally publishedYes

Fingerprint

DNA Damage
Phosphoric Monoester Hydrolases
Mutation
Neoplasms
Phenotype
Oncogenes
Single Nucleotide Polymorphism
Carcinogenesis

Keywords

  • ATM
  • Chk2
  • Genetic variants
  • Human cancer
  • Mutations
  • PPM1D
  • Wip1

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Cite this

Dudgeon, C., Shreeram, S., Tanoue, K., Mazur, S. J., Sayadi, A., Robinson, R. C., ... Bulavin, D. V. (2013). Genetic variants and mutations of PPM1D control the response to DNA damage. Cell Cycle, 12(16), 2656-2664. https://doi.org/10.4161/cc.25694

Genetic variants and mutations of PPM1D control the response to DNA damage. / Dudgeon, Crissy; Shreeram, Sathyavageeswaran; Tanoue, Kan; Mazur, Sharlyn J.; Sayadi, Ahmed; Robinson, Robert C.; Appella, Ettore; Bulavin, Dmitry V.

In: Cell Cycle, Vol. 12, No. 16, 15.08.2013, p. 2656-2664.

Research output: Contribution to journalArticle

Dudgeon, C, Shreeram, S, Tanoue, K, Mazur, SJ, Sayadi, A, Robinson, RC, Appella, E & Bulavin, DV 2013, 'Genetic variants and mutations of PPM1D control the response to DNA damage', Cell Cycle, vol. 12, no. 16, pp. 2656-2664. https://doi.org/10.4161/cc.25694
Dudgeon C, Shreeram S, Tanoue K, Mazur SJ, Sayadi A, Robinson RC et al. Genetic variants and mutations of PPM1D control the response to DNA damage. Cell Cycle. 2013 Aug 15;12(16):2656-2664. https://doi.org/10.4161/cc.25694
Dudgeon, Crissy ; Shreeram, Sathyavageeswaran ; Tanoue, Kan ; Mazur, Sharlyn J. ; Sayadi, Ahmed ; Robinson, Robert C. ; Appella, Ettore ; Bulavin, Dmitry V. / Genetic variants and mutations of PPM1D control the response to DNA damage. In: Cell Cycle. 2013 ; Vol. 12, No. 16. pp. 2656-2664.
@article{e78faa0111cd4ab4afb90030b0a363a5,
title = "Genetic variants and mutations of PPM1D control the response to DNA damage",
abstract = "The Wip1 phosphatase is an oncogene that is overexpressed in a variety of primary human cancers. We were interested in identifying genetic variants that could change Wip1 activity. We identified 3 missense SNPs of the human Wip1 phosphatase, L120F, P322Q, and I496V confer a dominant-negative phenotype. On the other hand, in primary human cancers, PPM1D mutations commonly result in a gain-of-function phenotype, leading us to identify a hot-spot truncating mutation at position 525. Surprisingly, we also found a significant number of loss-of-function mutations of PPM1D in primary human cancers, both in the phosphatase domain and in the C terminus. Thus, PPM1D has evolved to generate genetic variants with lower activity, potentially providing a better fitness for the organism through suppression of multiple diseases. In cancer, however, the situation is more complex, and the presence of both activating and inhibiting mutations requires further investigation to understand their contribution to tumorigenesis.",
keywords = "ATM, Chk2, Genetic variants, Human cancer, Mutations, PPM1D, Wip1",
author = "Crissy Dudgeon and Sathyavageeswaran Shreeram and Kan Tanoue and Mazur, {Sharlyn J.} and Ahmed Sayadi and Robinson, {Robert C.} and Ettore Appella and Bulavin, {Dmitry V.}",
year = "2013",
month = "8",
day = "15",
doi = "10.4161/cc.25694",
language = "English",
volume = "12",
pages = "2656--2664",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "16",

}

TY - JOUR

T1 - Genetic variants and mutations of PPM1D control the response to DNA damage

AU - Dudgeon, Crissy

AU - Shreeram, Sathyavageeswaran

AU - Tanoue, Kan

AU - Mazur, Sharlyn J.

AU - Sayadi, Ahmed

AU - Robinson, Robert C.

AU - Appella, Ettore

AU - Bulavin, Dmitry V.

PY - 2013/8/15

Y1 - 2013/8/15

N2 - The Wip1 phosphatase is an oncogene that is overexpressed in a variety of primary human cancers. We were interested in identifying genetic variants that could change Wip1 activity. We identified 3 missense SNPs of the human Wip1 phosphatase, L120F, P322Q, and I496V confer a dominant-negative phenotype. On the other hand, in primary human cancers, PPM1D mutations commonly result in a gain-of-function phenotype, leading us to identify a hot-spot truncating mutation at position 525. Surprisingly, we also found a significant number of loss-of-function mutations of PPM1D in primary human cancers, both in the phosphatase domain and in the C terminus. Thus, PPM1D has evolved to generate genetic variants with lower activity, potentially providing a better fitness for the organism through suppression of multiple diseases. In cancer, however, the situation is more complex, and the presence of both activating and inhibiting mutations requires further investigation to understand their contribution to tumorigenesis.

AB - The Wip1 phosphatase is an oncogene that is overexpressed in a variety of primary human cancers. We were interested in identifying genetic variants that could change Wip1 activity. We identified 3 missense SNPs of the human Wip1 phosphatase, L120F, P322Q, and I496V confer a dominant-negative phenotype. On the other hand, in primary human cancers, PPM1D mutations commonly result in a gain-of-function phenotype, leading us to identify a hot-spot truncating mutation at position 525. Surprisingly, we also found a significant number of loss-of-function mutations of PPM1D in primary human cancers, both in the phosphatase domain and in the C terminus. Thus, PPM1D has evolved to generate genetic variants with lower activity, potentially providing a better fitness for the organism through suppression of multiple diseases. In cancer, however, the situation is more complex, and the presence of both activating and inhibiting mutations requires further investigation to understand their contribution to tumorigenesis.

KW - ATM

KW - Chk2

KW - Genetic variants

KW - Human cancer

KW - Mutations

KW - PPM1D

KW - Wip1

UR - http://www.scopus.com/inward/record.url?scp=84883237156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883237156&partnerID=8YFLogxK

U2 - 10.4161/cc.25694

DO - 10.4161/cc.25694

M3 - Article

C2 - 23907125

AN - SCOPUS:84883237156

VL - 12

SP - 2656

EP - 2664

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 16

ER -